Quanterix Corporation (QTRX) News
Follow Quanterix Corporation (QTRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Quanterix Reports Quarterly Results for Quarter Ended September 30
The headline reports results for the quarter ended September 30; the supplied body contains no results figures.
EQUITY | Nov 09, 2026, 02:31 PM UTC
M
Quanterix Q3 Revenue Rises 6.3% Sequentially
EQUITY | Nov 09, 2026, 01:15 PM UTC
L
Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026
Quanterix Corporation (NASDAQ: QTRX) today reported significant progress on the Content Innovation Engine it introduced at the American Association for Cancer Research (AACR) Annual Meeting 2026, highlighting new updates
NEWS | Sep 25, 2026, 12:00 PM UTC
L
QTRX - Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
QTRX - Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWS | Sep 17, 2026, 01:03 AM UTC
L
Quanterix Lowers FY2026 Sales Guidance from $169.000M-$174.000M to $142.000M-$148.000M vs $169.930M Est
Quanterix (NASDAQ: QTRX ) lowers FY2026 sales outlook from $169.000 million-$174.000 million to $142.000 million-$148.000 million vs $169.930 million estimate.
EARNINGS | Aug 10, 2026, 12:00 PM UTC
L
Anthem Blue Cross, Blue Shield establish commercial coverage for LucentAD
Anthem Blue Cross, Blue Shield establish commercial coverage for LucentAD
EQUITY | Jul 14, 2026, 08:36 PM UTC